FINWIRES · TerminalLIVE
FINWIRES

$LBRX

2 stories mentioning LBRXUpdated 20d ago

Every FINWIRES story that references LBRX, newest first.

Research

BMO Capital Initiates LB Pharmaceuticals at Outperform With $46 Price Target

LB Pharmaceuticals, Inc. (LBRX) has an average rating of buy and mean price target of $45.11, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$LBRX
Research

HC Wainwright Initiates Coverage on LB Pharmaceuticals With Buy Rating, $45 Price Target

LB Pharmaceuticals Inc (LBRX) has an average rating of Buy and mean price target of $44, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$LBRX

Track with the FINWIRES app suite

FolioX
FolioX
Track LBRX in your portfolio
WheelAI
WheelAI
Analyze LBRX options with the wheel strategy
StockInsider
StockInsider
See market sentiment on LBRX